A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients

Inogés, Susana; Tejada, Sonia; López-Dı́az de Cerio, Ascensión; Gállego Pérez‐Larraya, Jaime; Espinós, J.; Á. Idoate, Miguel; Domínguez, Pablo; R. Garcia de Eulate, M.; Aristu, Javier; Bendandi, Maurizio; Pastor, Fernando; M. Alonso, Marta; J. Andreu, Enrique; Prósper Cardoso, Felipe; Díez Valle, Ricardo

doi:10.1186/s12967-017-1202-z

Public

A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients

Published in Journal of Translational Medicine • May 12, 2017

Authors:

Susana Inogés

Sonia Tejada

Ascensión López-Dı́az de Cerio

Abstract

BACKGROUND: Prognosis of patients with glioblastoma multiforme (GBM) remains dismal, with median overall survival (OS) of about 15 months. It is therefore crucial to search alternative strategies that improve these results obtained with conventional treatments. In this context, immunotherapy seems t...

Subject

Medicine

Temozolomide

Concomitant

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!